Skip to main content

Archive

BioPorto reveals 'healthy growth' in second quarter revenue

BioPorto reveals 'healthy growth' in second quarter revenue

BioPorto A/S (CPH:BIOPOR) CFO Ole Larsen tells Proactive the diagnostic company saw "healthy growth" in revenue for the second quarter, where revenue grew by 10% to DKK (Danish Krone) 7.8 million (US$1.16 million) compared to DKK 7.2 million (US$1.08 million) in the same period in the previous year.

Larsen says the two components that drove growth included increased revenues from its NGAL test in the US, up 43% in the quarter, and increased sales of antibodies.